Evaluation of COVID-19 Antigen Test Kit Assay Analytical and Clinical Performance

Objective To rapidly screen patients with novel coronavirus pneumonia (COVID-19) infection including asymptomatic ones. Method Established a rapid detection test kit, and evaluated analytical and clinical performance of it. Result The minimum limit of detection of the reagent was 9.75×102 TCID50/mL; there was no cross-reaction and interference in the high-concentration samples of 29 common respiratory pathogens tested. The diagnostic sensitivity of clinical samples was 98.56%, specificity was 99.00%, and the total coincidence rate was 98.85%; the consistency test Kappa value is 0.974 5. The stratified analysis of positive samples with different Ct values showed that the coincidence rate within each stratum was greater than 95%. Conclusion This COVID-19 antigen test kit with excellent detection performance, fast detection speed, and portable operation. It can be used as a supplementary method for existing nucleic acid detection methods for early screening of new coronavirus.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:47

Enthalten in:

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation - 47(2023), 1 vom: 30. Jan., Seite 99-105

Sprache:

Chinesisch

Beteiligte Personen:

Jiang, Xiaolu [VerfasserIn]
Du, Mingqiu [VerfasserIn]
Yang, Lancui [VerfasserIn]
Fan, Chenxia [VerfasserIn]
Zheng, Ming [VerfasserIn]

Links:

Volltext

Themen:

Analytical performance evaluation
Coronavirus infection
English Abstract
In vitro diagnostics
Journal Article
SARS-CoV-2

Anmerkungen:

Date Completed 09.02.2023

Date Revised 09.02.2023

published: Print

Citation Status MEDLINE

doi:

10.3969/j.issn.1671-7104.2023.01.018

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM352619325